8 research outputs found
Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults with Depression
Background: Depression is a common source of human disability for which etiologic insights remain limited. Although abnormalities of monoamine neurotransmission, including dopamine, are theorized to contribute to the pathophysiology of depression, evidence linking dopamine-related genes to depression has been mixed. The current study sought to address this knowledge-gap by examining whether the combined effect of dopamine polymorphisms was associated with depressive symptomatology in both healthy individuals and individuals with depression. Methods: Data were drawn from three independent samples: (1) a discovery sample of healthy adult participants (n = 273); (2) a replication sample of adults with depression (n = 1,267); and (3) a replication sample of healthy adult participants (n = 382). A genetic risk score was created by combining functional polymorphisms from five genes involved in synaptic dopamine availability (COMT and DAT) and dopamine receptor binding (DRD1, DRD2, DRD3). Results: In the discovery sample, the genetic risk score was associated with depressive symptomatology (β = −0.80, p = 0.003), with lower dopamine genetic risk scores (indicating lower dopaminergic neurotransmission) predicting higher levels of depression. This result was replicated with a similar genetic risk score based on imputed genetic data from adults with depression (β = −0.51, p = 0.04). Results were of similar magnitude and in the expected direction in a cohort of healthy adult participants (β = −0.86, p = 0.15). Conclusions: Sequence variation in multiple genes regulating dopamine neurotransmission may influence depressive symptoms, in a manner that appears to be additive. Further studies are required to confirm the role of genetic variation in dopamine metabolism and depression
Recommended from our members
Brain Genomics Superstruct Project initial data release with structural, functional, and behavioral measures
The goal of the Brain Genomics Superstruct Project (GSP) is to enable large-scale exploration of the links between brain function, behavior, and ultimately genetic variation. To provide the broader scientific community data to probe these associations, a repository of structural and functional magnetic resonance imaging (MRI) scans linked to genetic information was constructed from a sample of healthy individuals. The initial release, detailed in the present manuscript, encompasses quality screened cross-sectional data from 1,570 participants ages 18 to 35 years who were scanned with MRI and completed demographic and health questionnaires. Personality and cognitive measures were obtained on a subset of participants. Each dataset contains a T1-weighted structural MRI scan and either one (n=1,570) or two (n=1,139) resting state functional MRI scans. Test-retest reliability datasets are included from 69 participants scanned within six months of their initial visit. For the majority of participants self-report behavioral and cognitive measures are included (n=926 and n=892 respectively). Analyses of data quality, structure, function, personality, and cognition are presented to demonstrate the dataset’s utility
Recommended from our members
Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults with Depression
Adjusted association between dopamine score and depressive symptoms.
<p>Cell entries are beta coefficients, standard errors (s.e.), p-values and 95% confidence intervals (CI). The HS model controlled for race/ethnicity. The STAR*D model contained controls for age (continuous), sex (0 = male; 1 = female); marital status (0 = married/cohabiting; 1 = never married; 2 = divorced, widowed, or separated); and five principle components for genetic ancestry/population stratification. The GSP model controlled for age (continuous), sex (0 = male; 1 = female), and four principle components for genetic ancestry/population stratification. Depressive symptoms were measured by 3 scales: CES-D (HS), HAM-D (STAR*D), POMS short form (GSP).</p
Summary of polymorphisms and classification for the genetic risk score.
<p>Summary of polymorphisms and classification for the genetic risk score.</p
Adjusted association between individual dopamine variants and depressive symptoms.
<p>Cell entries are beta coefficients, standard errors (s.e.), p-values and 95% confidence intervals (CI). The HS model controlled for race/ethnicity.</p